What is PowerVision?
Headquartered in Belmont, California, PowerVision operates as a specialized player in the Medical Devices & Equipment industry. With a lean team of 10 to 19 professionals, the company has maintained a robust revenue profile, estimated between 5M and 10M. The firm focuses on the development of sophisticated medical technologies, leveraging its strategic location in the California innovation hub to drive advancements in patient care and diagnostic precision. Its market position is bolstered by a history of collaboration with industry-leading healthcare technology firms and venture capital institutions.
How much funding has PowerVision raised?
PowerVision has raised a total of $93.5M across 4 funding rounds:
Series A
$4.4M
Series B
$20M
Series C
$24M
Series D
$45.1M
Series A (2005): $4.4M with participation from JPMorgan Partners (JPMP) and Frazier Healthcare Partners
Series B (2007): $20M led by Frazier Healthcare Ventures, Advanced Technology Ventures, and JPMorgan Chase
Series C (2011): $24M supported by Advanced Technology Ventures, Frazier Healthcare Ventures, Medtronic, Inc., Panorama Capital, and Venrock
Series D (2014): $45.1M featuring Correlation Venture Partners, Lexington Partners, Advanced Technology Ventures, Johnson & Johnson Development Corporation, Frazier Healthcare Ventures, Aisling Capital, BA Venture Partners, Medtronic, Inc., and Venrock
Key Investors in PowerVision
Advanced Technology Ventures
A bi-coastal venture capital firm with over 35 years of experience, specializing in building emerging-growth business ventures into market leaders across healthcare and IT infrastructure.
Frazier Healthcare Ventures
A specialized investment firm focused on the biopharmaceutical and healthcare sectors, dedicated to developing and commercializing innovative treatments and medical solutions.
Medtronic, Inc.
A global leader in healthcare technology that develops and manufactures medical devices and therapies, collaborating with providers to improve patient outcomes worldwide.
What's next for PowerVision?
Looking ahead, the recent capital injection provides PowerVision with the necessary runway to accelerate its product development pipeline and expand its market footprint. Given the company's history of securing backing from major healthcare technology players, the current strategic focus likely involves scaling manufacturing capabilities and deepening its penetration into global medical markets. As the firm continues to mature, the emphasis will remain on translating its technological innovations into sustainable, long-term value for both healthcare providers and patients, while maintaining the operational agility that has defined its growth to date.
See full PowerVision company page
